Clinical trial
RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM
NCT00457964 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00457964 |
|---|---|
| Title | RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM |
| Official title | RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | Novartis Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Tuberous Sclerosis, Lymphangioleiomyomatosis |
| Intervention type | Drug |
| Interventions | RAD001 |
| Enrollment | 36 |
| Start date | Aug 1, 2005 |
| Primary completion | Jul 1, 2013 |
| Completion | Jul 1, 2013 |
| First posted | Apr 9, 2007 |
| Last update posted | Sep 25, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: